Pnasier Overview
- Year Founded
-
2023
- Status
-
Private
- Employees
-
7
- Latest Deal Type
-
Early Stage VC
- Investors
-
7
Pnasier General Information
Description
Developer of a drug delivery platform designed to enhance the performance of approved pharmaceutical compounds. The company utilizes a proprietary bio-nanoparticle platform and simultaneous self-assembly technology to create a porous polymer matrix for drug encapsulation, enabling pharmaceutical manufacturers to streamline production and improve therapeutic delivery precision.
Contact Information
Website
www.pnaseer.comCorporate Office
- 25 Beopjo-ro
- Yeongtong-gu, Gwanggyo SK VIEW Lake, A-dong 1309
- Busan, Gyeonggi
- South Korea
Corporate Office
- 25 Beopjo-ro
- Yeongtong-gu, Gwanggyo SK VIEW Lake, A-dong 1309
- Busan, Gyeonggi
- South Korea
Pnasier Timeline
Pnasier Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Early Stage VC | 09-Nov-2026 | Completed | Generating Revenue | |||
| 5. Seed Round | 28-Aug-2024 | Completed | Generating Revenue | |||
| 4. Accelerator/Incubator | 01-Jan-2024 | Completed | Generating Revenue | |||
| 3. Accelerator/Incubator | 01-Jan-2024 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | Completed | Startup | ||||
| 1. Accelerator/Incubator | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Pnasier Patents
Pnasier Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2024362372-A1 | Bio-particle encapsulated hydrogel using aqueous-two phase system and method for producing same | Pending | 19-Oct-2023 | ||
| EP-4796213-A1 | Bio-particle encapsulated hydrogel using aqueous-two phase system and method for producing same | Pending | 19-Oct-2023 | ||
| WO-2025084854-A1 | Bio-particle encapsulated hydrogel using aqueous-two phase system and method for producing same | Inactive | 19-Oct-2023 | ||
| EP-4717699-A1 | Method for concentrating regeneration factor in blood by using aqueous two-phase system | Pending | 23-May-2023 | ||
| WO-2024242454-A1 | Method for concentrating regeneration factor in blood by using aqueous two-phase system | Inactive | 23-May-2023 | C07K1/145 |
Pnasier Signals
Pnasier Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| IBK Capital (Korea) | Lender/Debt Provider | Minority | ||
| Innopolis Partners | Venture Capital | Minority | ||
| TheVentures Company | Venture Capital | Minority | ||
| COMEUP STARS | Accelerator/Incubator | |||
| Tech Incubator Program for Startup | Accelerator/Incubator |
Pnasier FAQs
-
When was Pnasier founded?
Pnasier was founded in 2023.
-
Where is Pnasier headquartered?
Pnasier is headquartered in Busan, South Korea.
-
What is the size of Pnasier?
Pnasier has 7 total employees.
-
What industry is Pnasier in?
Pnasier’s primary industry is Drug Delivery.
-
Is Pnasier a private or public company?
Pnasier is a Private company.
-
What is Pnasier’s current revenue?
The current revenue for Pnasier is .
-
How much funding has Pnasier raised over time?
Pnasier has raised $2.53M.
-
Who are Pnasier’s investors?
IBK Capital (Korea), Innopolis Partners, TheVentures Company, COMEUP STARS, and Tech Incubator Program for Startup are 5 of 7 investors who have invested in Pnasier.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process